Faes Farma SA operates as a pharmaceutical company. It engages in manufacturing and sale of chemical and pharmaceutical products, as well as the acquisition, purchase, sale, investment, holding, administration, management, negotiation and leasing of companies, of transferable and immovable securities, patents, trademarks and registrations and social participations. The company was founded in 1933 and is headquartered in Leioa, Spain.

Disproquima SA is a Spanish private company with a presence in several countries. The firm manufactures and wholesales chemical products for pharmacy, beauty & health industries.

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Wanquan Wante Pharmaceutical Jiangsu Co., Ltd., established on 2009-07-15, Business range includes tablet,Capsules,Granules,Powder,soft capsule,small volume injection,Freeze-dried powder injection,gel,ointment,suppositories,cream,Production of raw materials.tablet,Capsules,Granules,Powder,soft capsule,small volume injection,Freeze-dried powder injection,gel,ointment,suppositories,cream,API R&D,Research on Bioengineering Preparations,biopharmaceuticals,chemical agent,Technology transfer of chemical raw materials,Technical Consulting and Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Founded in 1963 in Hamburg by the company’s namesake Alfred E. Tiefenbacher as the world’s first exclusive API agency (active pharmaceuticals ingredient). AET has been growing successfully in the global pharmaceutical market for more than 50 years. Representing API producers has provided the foundation for AET’s growth into a pharmaceutical company capable of independently developing, registering and supplying finished dosage form (FDF) generic pharmaceuticals to marketing organisations internationally. AET enjoys an industry leading reputation for technical excellence and service.

Symed Laboratories Ltd., part of Viyash Life Sciences Pvt Ltd., is an Indian company located in Hyderabad. The firm manufactures pharmaceutical ingredients. It was founded in 1997. Mohan Rao Dodda is currently the CEO of the company. Viyash Life Sciences Pvt Ltd. acquired Symed Laboratories Ltd. on July 31, 2021.

Shandong Luoxin Pharmaceutical Group Hengxin Pharmaceutical Co., Ltd., established on 2011-04-11, The business scope includes Chinese and Western medicines,Development of pharmaceutical raw materials,to develop;API,Antitumor raw materials,Sterile API,Chemical raw materials for pharmaceutical production,Production of excipients and intermediates,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Hangzhou Lide Biotechnology Co., Ltd., established on 2014-10-23, Business scope includes technology development,technical consulting:Biotechnology,Biological product;Sales:the first sort,Class II medical device,Chemical raw materials and products(Removal of dangerous chemicals and precursor drugs);Import and export(law,Except for items prohibited by administrative regulations,law,Projects that are restricted by administrative regulations can only be operated after obtaining a license).

Chongqing Huabang Shengkai Pharmaceutical Co., Ltd., established on 2009-08-28, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Chemical product sales(No licensed chemical products);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Changao Pharmaceutical Science & Technology Co. Ltd., a subsidiary of Shionogi & Co., Ltd., is a Chinese company located in Nanjing that manufactures and distributes pharmaceutical products. On January 11, 2006 C&O Pharmaceutical Technology (Holdings) Ltd., now a subsidiary of Shionogi & Co., Ltd. acquired Nanjing Changao Pharmaceutical Science & Technology Co. Ltd. for $0.09 million.

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Seattle Gummy Company is a specialty pharmaceutical company focusing on delivering active pharmaceutical ingredients (APIs) using innovative gummy (semi-solid chewable gel) formulations. Soft and chewable gummy formulation is a perfect delivery carrier for medications, especially for populations having problem swallowing pills and capsules. Children younger than 6 generally lack fully developed gag reflex and could not swallow solid dosage forms. In addition, one in every 25 adults in US has swallowing problems. Syrup is often gooey, hard to measure and prone to spill. Making it difficult to accurately dose and treat the patient, which leads to ineffective treatment, medication waste, and significant patient compliance issue. SGC provides a perfect solution for these problems. Building upon its proprietary API-Complexing technology and sugar-free GUMMY ZERO® matrix protected by a large and robust IP portfolio, the company has developed stable and great tasting gummy drugs treating varieties of diseases. With the initial focus on pediatric and geriatric markets, SGC’s current drug development program features a suite of gummy drugs for treating allergy, pain, fever, cough, nausea, insomnia, inflammatory, cardiovascular conditions, and bacterial infection. The company has a diverse gummy drug pipeline in the regulatory approval process and has received the FDA approval for its IND of the very first gummy drug formulation in the world.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Shanghai Tianci Zhongshang Pharmaceutical Co., Ltd., established on 2014-02-18, Business scope includes licensed projects:food sales;pharmaceutical production;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Sales of Class I Medical Devices;housing lease;Non-residential real estate leases;property management;Financial Advisory;Business Management Consulting;Socioeconomic Advisory Services;Corporate Image Planning;Graphic design and production;Urban Greening Management;Conference and Exhibition Services;Sales of office equipment consumables;Instrument sales;electronic,Mechanical equipment maintenance(No special equipment);Environmental protection special equipment sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture, sale, research and development of pharmaceutical products. Its products include anti-infective, antiviral, respiratory system, digestive system, nervous, endocrine, cardiovascular system, antipyretic, analgesics & anti-inflammatory, oncology, anti-allergic APIs & intermediates, lyophilized powder for injection preparation, solid preparation, chemical raw medicine, cephalosporin raw medicine and oral cephalosporin series. The company was founded on December 14, 1995 and is headquartered in Linyi, China.

Shandong Yuxin Pharmaceutical Co., Ltd., established on 2010-12-30, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Disinfectant production(Free of Hazardous Chemicals);Catering Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Pharmaceutical commissioned production;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of labor protection products;Sales of labor protection products;Disinfectant sales(Free of Hazardous Chemicals);Medical Research and Experimental Development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chongqing Huapont Pharmaceutical Co. Ltd., part of Huapont Life Sciences Co., Ltd., is a company headquartered in Chongqing, China. The firm manufactures pharmaceutical products.

Beijing Kelaibo Pharmaceutical Development Co., Ltd., established on 2002-10-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Technology Import and Export;Import and export;Import and export agency;Sales of Class I Medical Devices;Cosmetics Retail;Chemical product sales(No licensed chemical products);Sales of daily chemical products;Daily necessities sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:food sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hubei Inners Biotechnology Co., Ltd., established on 2020-08-06, Business scope includes technology development in medicinal chemistry and bioengineering and related fields,technology transfer,technical consulting;Production of pharmaceutical raw materials and preparations,Research,to develop;biotechnology products,medical products,Chemical Products(Does not contain dangerous goods)research and development,Sales,Technical Services,technology transfer.(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)